Feedback / Questions
muzastotug (ADG126) - Adagene
https://www.globenewswire.com/news-release/2025/10/31/3178218/0/en/Adagene-Announces-First-Patient-Dosed-in-Randomized-Dose-Optimization-Cohort-of-the-Phase-2-Study-of-Muzastotug-ADG126-in-Combination-with-KEYTRUDA-pembrolizumab-in-Microsatellite-.html
Oct 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next